Enter assignee name

EPO Patents = 1

Trademarks = 1

Forward Citations = 23

Loading Chart...

6 inventors (with patents filed for the assignee):

Asa Abeliovich (11 out of 13 patents)

Herve Rhinn (11 out of 11 patents)

Laura Heckman (11 out of 11 patents)

4. Franz Hefti (2 out of 2 patents)

5. Li Chin Wong (1 out of 1 patent)

6. Hsuan-Ni Lin (1 out of 1 patent)

11 patents: Sort by Forward Citations

1. 12049626 - Gene therapy for neurodegenerative disorders (2024-07-30),

2. 11999974 - Gene therapies for lysosomal disorders (2024-06-04),

3. 11993790 - Gene therapies for lysosomal disorders (2024-05-28),

4. 11903985 - Gene therapies for lysosomal disorders (2024-02-20),

5. 11807849 - Gene therapies for lysosomal disorders (2023-11-07),

6. 11802294 - Gene therapies for lysosomal disorders (2023-10-31),

7. 11661585 - Gene therapies for lysosomal disorders (2023-05-30),

8. 11655460 - Gene therapies for lysosomal disorders (2023-05-23),

9. 11060113 - Gene therapies for lysosomal disorders (2021-07-13),

10. 10837028 - Gene therapies for lysosomal disorders (2020-11-17),

11. 10689625 - Gene therapies for lysosomal disorders (2020-06-23),

Prevail Therapeutics is a biotechnology company developing gene therapies for patients with neurodegenerative diseases. They are focused on utilizing adeno-associated virus vectors to deliver gene therapies that target underlying genetic causes of diseases such as Parkinson's and Gaucher. Their mission is to provide transformative treatments for patients with limited or no treatment options.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 23 2025

11 Patents

#578 in New York, NY

#1,496 in New York

#26,696 in US

#50,205 in the World

New York, NY, United States of America

Prevail Therapeutics, Inc.